Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 January 2019 | Story Zama Feni | Photo Barend Nagel
Prof Matlabisa
Prof Motlalepula Matlabisa of the Department of Pharmacology.

Two South African government departments have granted the University of the Free State’s Department of Pharmacology a combined amount of R15 million for the establishment of four tea farms in the disadvantaged communities in the North West and Eastern Cape Communities.

The head of the project Prof Motlalepula Matsabisa at the Department of Pharmacology said that that Department of Environmental Affairs (DEA) has granted an amount of R10 million for the community research in the respective provinces.

This grant is a top up to the R5 million they received from the Department of Science and Technology for the “community implementation on indigenous health infusions or teas as commonly known.”

The DEA will in the near future sign a Memorandum of Agreement (MOA) with the university.


Tea project set to empower communities


“The project is to implement and build structures in the four communities we work with in the North West and Eastern Cape,” he said.

The identified areas for the project are in the Eastern Cape towns of Alice and Idutywa as well another two North West communities in Zeerust.

Prof Matsabisa indicated that the project will be a manifestation of “how science can contribute to economic growth, poverty alleviation and job creation.” 

“It was very interesting to have discovered that some French and German companies have already displayed interest in the projects,” he said.

He stated that a project of this nature is a good initiative by the UFS and it will also show that the university’s research activities are national. “We have been researching and developing indigenous teas which have now attracted interest locally and internationally by huge companies such as Nestle, Tiger Brands, Moringa World etc,” he said. 


Taking it slowly


At the initial stages of the tea farming project, Prof Matsabisa said they would start in small portions of utilising five hectares in each of the four projects and as the project gains momentum, they would expand.

Prof Matlabisa said that an environmental impact assessment has already been conducted and they were waiting for the DEA to give them a go ahead for the land preparations.



News Archive

Link between champagne bubbles and the UFS?
2012-11-16

Prof. Lodewyk Kock with an example of a front page of the publication FEMS Yeast Research, as adapted by F. Belliard, FEMS Central Office.
Photo: Leatitia Pienaar
15 November 2012

What is the link between the bubbles in champagne and breakthrough research being done at the Mayo Clinic in America? Nano research being done at our university.

Prof. Lodewyk Kock of Biotechnology says a human being consists of millions of minute cells that are invisible to the eye. The nano technology team at the UFS have developed a technique that allows researchers to look into such a cell, as well as other microorganisms. In this way, they can get an idea of what the cell’s “insides” look like.

The UFS team – consisting of Profs. Kock, Hendrik Swart (Physics), Pieter van Wyk (Centre for Microscopy), as well as Dr Chantel Swart (Biotechnology), Dr Carlien Pohl (Biotechnology) and Liza Coetsee (Physics) – were amazed to see that the inside of cells consist of a maze of small tunnels or blisters. Each tunnel is about 100 and more nanometres in diameter – about one ten thousandth of a millimetre – that weaves through the cells in a maze.

It was also found that these tunnels are the “lungs” of the cells. Academics doing research on yeast have had to sit up and take notice of the research being done at the UFS – to the extent that these “lungs” will appear on the front page of the highly acclaimed FEMS Yeast Research for all of 2013.

The Mayo Clinic, in particular, now wants to work with the UFS to study cancer cells in more detail in order to fight this disease, says Prof. Kock. The National Cancer Institute of America has also shown interest. This new nano technology for biology can assist in the study and development of nano medicine that can be used in the treatment of cancer and other life threatening diseases. Nano medicine uses nano metal participles that are up to one billionth of a metre in size.

Prof. Kock says laboratory tests indicate that nano medicine can improve the efficacy of anti-cancer medicine, which makes the treatment less toxic. “According to the Mayo Clinic team, nano particles are considered as a gold cartridge which is being fired directly at a cancer tumour. This is compared to fine shot that spreads through the body and also attacks healthy cells.”

“This accuracy implies that the chemotherapy dose can be lowered with fewer side effects. The Mayo Clinic found that one-tenth of the normal dosage is more effective against pancreas cancer in this way than the full dosage with a linkage to nano particles. According to the clinic, this nano medicine could also delay the spread of cancer,” says Prof. Kock.

The nano particles are used as messengers that convey anti-cancer treatment to cancer cells, where it then selectively kills the cancer cells. The transport and transfer of these medicines with regard to gold nano particles can be traced with the UFS’s nano technology to collect more information, especially where it works on the cell.

“With the new nano technology of the UFS, it is possible to do nano surgery on the cells by slicing the cells in nanometre thin slices while the working of the nano medicine is studied. In this way, it can be established if the nano medicine penetrates the cells or if it is only associated with the tiny tunnels,” says Prof. Kock.

And in champagne the small “lungs” are responsible for the bubbles. The same applies to beer and with this discovery a whole new reach field opens for scientists.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept